Latest News & Features
Americas
The Patent Trial and Appeal Board’s process of allowing the same three judges to decide whether to institute an inter partes review and on the validity of the patent in question creates legal biases, Ethicon Endo-Surgery has argued. 1 March 2016
Big Pharma
The European Commission is considering whether ‘export waivers’ should be introduced in order to partly relax the rules on supplementary protection certificates. Gareth Morgan of Olswang explains more. 1 March 2016
Africa
Pharmaceutical company Teva is set to re-brand itself as part of its plan to build “a new breed of healthcare company”. 29 February 2016
Americas
The US Court of Appeals for the Federal Circuit has invalidated a polymer patent owned by Howmedica Osteonics, reversing an earlier decision from the US Patent and Trademark Office and ending the company’s long running dispute with medical device company Zimmer. 29 February 2016
Americas
Californian genetic analysis company Illumina has sued UK-based Oxford Nanopore Technologies, which develops nanopore sequencing products. 26 February 2016
Americas
Law firm Holland & Knight has hired Merri Moken as a partner in its intellectual property practice in New York. 25 February 2016
Americas
The Coalition for Affordable Drugs and Anacor Pharmaceuticals will face off in a dispute over the validity of two anti-fungal patents after the Patent Trial and Appeal Board gave the go-ahead to two inter partes review petitions. 25 February 2016
Americas
Counterfeiting poses one of the greatest threats to the pharmaceutical industry, but there are good reasons to believe that companies are tackling the problem head on. Stephen Ward of Pinkerton reports. 25 February 2016
Americas
Pharmaceutical company Codexis has sued a rival and its founder for allegedly stealing trade secrets and infringing up to ten patents. 24 February 2016
Americas
Hedge fund manager Kyle Bass has returned almost $700 million to investors that backed his inter partes review challenges, but has vowed to continue challenging pharmaceutical patents after being given the green light to tackle another. 24 February 2016